Skip to main content

Table 3 Cerebral flow-mediated dilation

From: Effects of continuous hypoxia on flow-mediated dilation in the cerebral and systemic circulation: on the regulatory significance of shear rate phenotype

Time

2 h

4 h

6 h

P values

Trial

Normoxia

Hypoxia

Normoxia

Hypoxia

Normoxia

Hypoxia

Time

Trial

Interaction

Dbase (mm)

5.1 ± 0.7

5.3 ± 0.6

5.3 ± 0.7

5.4 ± 0.6

5.1 ± 0.6

5.2 ± 0.5

0.360

 < 0.001

0.742

Dpeak (mm)

5.3 ± 0.7

5.5 ± 0.7

5.5 ± 0.6

5.6 ± 0.6

5.3 ± 0.6

5.4 ± 0.6

0.451

 < 0.001

0.724

ΔD (mm)

0.20 ± 0.13

0.20 ± 0.12

0.21 ± 0.06

0.20 ± 0.10

0.21 ± 0.12

0.23 ± 0.12

0.872

0.860

0.959

SRAUC (a.u.)

47,490 ± 19,884

38,783 ± 15,567

45,474 ± 15,207

39,963 ± 14,721

41,379 ± 11,867

36,376 ± 10,821

0.413

0.059

0.972

Peak time (s)

148 ± 36

138 ± 27

148 ± 17

143 ± 25

141 ± 27

134 ± 37

0.784

0.454

0.983

  1. Values are mean ± SD
  2. Dbase baseline diameter, Dpeak peak diameter, ΔD the change in diameter from Dbase to Dpeak, SRAUC shear rate area under the curve from the onset of hyperemia to peak dilation; Peak time, time to peak dilation from the onset of hyperemia
  3. Bold p-values denote a p-value less than P<0.05. The Bold has now been removed